Bare Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Bare Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$607	Buy	+21	New	+$516	﹤0.01%	1669

Other funds holding ADPT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bare Financial Services's ADPT Position: Q3 2026 in Review

Bare Financial Services opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 21 shares worth $607. The stake represents ﹤0.01% of the portfolio and ranks #1669 among its holdings.

116 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

Bare Financial Services held 21 shares of Adaptive Biotechnologies worth $607 as of Q3 2026.
Adaptive Biotechnologies was a new Bare Financial Services position in Q3 2026.
Adaptive Biotechnologies made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #1669 holding.
116 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.